134 related articles for article (PubMed ID: 25673043)
1. Formulation, Characterization, and Antitumor Properties of Trans- and Cis-Citral in the 4T1 Breast Cancer Xenograft Mouse Model.
Zeng S; Kapur A; Patankar MS; Xiong MP
Pharm Res; 2015 Aug; 32(8):2548-58. PubMed ID: 25673043
[TBL] [Abstract][Full Text] [Related]
2. Antitumor and Anti-Metastatic Effects of Citral-Loaded Nanostructured Lipid Carrier in 4T1-Induced Breast Cancer Mouse Model.
Nordin N; Yeap SK; Rahman HS; Zamberi NR; Mohamad NE; Abu N; Masarudin MJ; Abdullah R; Alitheen NB
Molecules; 2020 Jun; 25(11):. PubMed ID: 32526880
[TBL] [Abstract][Full Text] [Related]
3. In Vivo Anti-Tumor Effects of Citral on 4T1 Breast Cancer Cells via Induction of Apoptosis and Downregulation of Aldehyde Dehydrogenase Activity.
Nigjeh SE; Yeap SK; Nordin N; Rahman H; Rosli R
Molecules; 2019 Sep; 24(18):. PubMed ID: 31492037
[TBL] [Abstract][Full Text] [Related]
4. Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3.
Thomas ML; de Antueno R; Coyle KM; Sultan M; Cruickshank BM; Giacomantonio MA; Giacomantonio CA; Duncan R; Marcato P
Mol Oncol; 2016 Nov; 10(9):1485-1496. PubMed ID: 27592281
[TBL] [Abstract][Full Text] [Related]
5. PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy.
Wang Y; Chen L; Tan L; Zhao Q; Luo F; Wei Y; Qian Z
Biomaterials; 2014 Aug; 35(25):6972-85. PubMed ID: 24836952
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of inhibition of aldehyde dehydrogenase by citral, a retinoid antagonist.
Kikonyogo A; Abriola DP; Dryjanski M; Pietruszko R
Eur J Biochem; 1999 Jun; 262(3):704-12. PubMed ID: 10411631
[TBL] [Abstract][Full Text] [Related]
7. Antifungal Activities of
Zheng Y; Shang Y; Li M; Li Y; Ouyang W
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299538
[No Abstract] [Full Text] [Related]
8. PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery.
Chu B; Qu Y; Huang Y; Zhang L; Chen X; Long C; He Y; Ou C; Qian Z
Int J Pharm; 2016 Mar; 500(1-2):345-59. PubMed ID: 26794876
[TBL] [Abstract][Full Text] [Related]
9. Effect of citral on the cytotoxicity of doxorubicin in human B-lymphoma cells.
Dangkong D; Limpanasithikul W
Pharm Biol; 2015 Feb; 53(2):262-8. PubMed ID: 25243873
[TBL] [Abstract][Full Text] [Related]
10. Targets and pathways involved in the antitumor activity of citral and its stereo-isomers.
Bailly C
Eur J Pharmacol; 2020 Mar; 871():172945. PubMed ID: 31981590
[TBL] [Abstract][Full Text] [Related]
11. Bioreducible PAA-g-PEG graft micelles with high doxorubicin loading for targeted antitumor effect against mouse breast carcinoma.
Sun Y; Zou W; Bian S; Huang Y; Tan Y; Liang J; Fan Y; Zhang X
Biomaterials; 2013 Sep; 34(28):6818-28. PubMed ID: 23764117
[TBL] [Abstract][Full Text] [Related]
12. Anticancer therapeutic potential of Mn porphyrin/ascorbate system.
Tovmasyan A; Sampaio RS; Boss MK; Bueno-Janice JC; Bader BH; Thomas M; Reboucas JS; Orr M; Chandler JD; Go YM; Jones DP; Venkatraman TN; Haberle S; Kyui N; Lascola CD; Dewhirst MW; Spasojevic I; Benov L; Batinic-Haberle I
Free Radic Biol Med; 2015 Dec; 89():1231-47. PubMed ID: 26496207
[TBL] [Abstract][Full Text] [Related]
13. A novel micelle of coumarin derivative monoend-functionalized PEG for anti-tumor drug delivery: in vitro and in vivo study.
Lai Y; Long Y; Lei Y; Deng X; He B; Sheng M; Li M; Gu Z
J Drug Target; 2012 Apr; 20(3):246-54. PubMed ID: 22118403
[TBL] [Abstract][Full Text] [Related]
14. Cross-reactivity between citral and geraniol - can it be attributed to oxidized geraniol?
Hagvall L; Bråred Christensson J
Contact Dermatitis; 2014 Nov; 71(5):280-8. PubMed ID: 25209002
[TBL] [Abstract][Full Text] [Related]
15. Biodegradable polymeric micelle-encapsulated quercetin suppresses tumor growth and metastasis in both transgenic zebrafish and mouse models.
Wu Q; Deng S; Li L; Sun L; Yang X; Liu X; Liu L; Qian Z; Wei Y; Gong C
Nanoscale; 2013 Dec; 5(24):12480-93. PubMed ID: 24165931
[TBL] [Abstract][Full Text] [Related]
16. Phospholipid-stabilized mesoporous carbon nanospheres as versatile carriers for systemic delivery of amphiphobic SNX-2112 (a Hsp90 inhibitor) with enhanced antitumor effect.
Zhang X; Zhang T; Ye Y; Chen H; Sun H; Zhou X; Ma Z; Wu B
Eur J Pharm Biopharm; 2015 Aug; 94():30-41. PubMed ID: 25936860
[TBL] [Abstract][Full Text] [Related]
17. Bio-functional micelles self-assembled from a folate-conjugated block copolymer for targeted intracellular delivery of anticancer drugs.
Liu SQ; Wiradharma N; Gao SJ; Tong YW; Yang YY
Biomaterials; 2007 Mar; 28(7):1423-33. PubMed ID: 17141308
[TBL] [Abstract][Full Text] [Related]
18. Stable and efficient delivery of docetaxel by micelle-encapsulation using a tripodal cyclotriphosphazene amphiphile.
Jun YJ; Jadhav VB; Min JH; Cui JX; Chae SW; Choi JM; Kim IS; Choi SJ; Lee HJ; Sohn YS
Int J Pharm; 2012 Jan; 422(1-2):374-80. PubMed ID: 22079718
[TBL] [Abstract][Full Text] [Related]
19. Encapsulated paclitaxel nanoparticles exhibit enhanced anti-tumor efficacy in A549 non-small lung cancer cells.
Huang G; Zang B; Wang X; Liu G; Zhao J
Acta Biochim Biophys Sin (Shanghai); 2015 Dec; 47(12):981-7. PubMed ID: 26525950
[TBL] [Abstract][Full Text] [Related]
20. Dual thermoresponsive and pH-responsive self-assembled micellar nanogel for anticancer drug delivery.
Chen D; Yu H; Sun K; Liu W; Wang H
Drug Deliv; 2014 Jun; 21(4):258-64. PubMed ID: 24102086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]